Midamor

Polyuria, Ascites, Hypokalemia + 7 more
Treatment
5 FDA approvals
20 Active Studies for Midamor

What is Midamor

AmilorideThe Generic name of this drug
Treatment SummaryAmiloride is a drug used to prevent the loss of potassium in the body. It works by blocking the reabsorption of sodium in the kidneys, which in turn creates a negative charge that reduces the secretion of potassium and hydrogen ions. Amiloride is usually taken with other diuretics to increase its effectiveness.
Amiloride Hydrochlorideis the brand name
image of different drug pills on a surface
Midamor Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Amiloride Hydrochloride
Amiloride
1986
23

Approved as Treatment by the FDA

Amiloride, otherwise called Amiloride Hydrochloride, is approved by the FDA for 5 uses like Congestive Heart Failure (CHF) and Hypokalemia .
Congestive Heart Failure (CHF)
Used in combination with other therapies
Hypokalemia
Congestive Heart Failure
Used in combination with other therapies
kaliuretic diuretics
Hypertensive disease

Effectiveness

How Midamor Affects PatientsAmiloride is a medication used to treat high blood pressure and congestive heart failure. It is an antihypertensive, potassium-sparing diuretic, meaning it helps the body get rid of extra fluids while also helping to keep potassium levels in the blood normal. It is often taken together with other diuretics. High levels of potassium in the blood (hyperkalemia) can occur when taking amiloride, especially if it is combined with ACE inhibitors or spironolactone. People taking this drug should avoid using salt replacements that contain potassium.
How Midamor works in the bodyAmiloride works by preventing sodium from being reabsorbed in the kidneys. This causes sodium and water to be excreted from the body, but it does not reduce potassium levels. Amiloride does this by blocking sodium channels in the distal convoluted tubules and collecting ducts. This reduces the negative charge in the tubular lumen, which stops potassium and hydrogen from being secreted. Amiloride does not need aldosterone to work.

When to interrupt dosage

The proposed dosage of Midamor is contingent upon the diagnosed state, including Metabolic Alkalosis, Bartter's syndrome and Congestive Heart Failure. The measure of dosage is subject to the method of delivery (e.g. Oral or Tablet) enumerated in the table underneath.
Condition
Dosage
Administration
Congestive Heart Failure
, 5.0 mg
, Tablet, Oral, Tablet - Oral
Hypertensive disease
, 5.0 mg
, Tablet, Oral, Tablet - Oral
Ascites
, 5.0 mg
, Tablet, Oral, Tablet - Oral
lithium
, 5.0 mg
, Tablet, Oral, Tablet - Oral
Bartter Syndrome
, 5.0 mg
, Tablet, Oral, Tablet - Oral
kaliuretic diuretics
, 5.0 mg
, Tablet, Oral, Tablet - Oral
Nephrolithiasis
, 5.0 mg
, Tablet, Oral, Tablet - Oral
Hypokalemia
, 5.0 mg
, Tablet, Oral, Tablet - Oral
Polyuria
, 5.0 mg
, Tablet, Oral, Tablet - Oral
Metabolic Alkalosis
, 5.0 mg
, Tablet, Oral, Tablet - Oral

Warnings

Midamor possesses four contraindications and should not be consumed in cases of the conditions identified in the table below.Midamor Contraindications
Condition
Risk Level
Notes
Renal Insufficiency
Do Not Combine
Hyperkalemia
Do Not Combine
potassium supplementation
Do Not Combine
Pulse Frequency
Do Not Combine
There are 20 known major drug interactions with Midamor.
Common Midamor Drug Interactions
Drug Name
Risk Level
Description
Cisplatin
Major
The serum concentration of Cisplatin can be increased when it is combined with Amiloride.
Clofarabine
Major
The serum concentration of Clofarabine can be increased when it is combined with Amiloride.
Cyclosporine
Major
The risk or severity of hyperkalemia can be increased when Amiloride is combined with Cyclosporine.
Dalfampridine
Major
The serum concentration of Dalfampridine can be increased when it is combined with Amiloride.
Gentamicin
Major
The serum concentration of Gentamicin can be increased when it is combined with Amiloride.
Midamor Toxicity & Overdose RiskTaking too much amiloride hydrochloride can be dangerous, as the lethal dose in mice is 56 mg/kg and 36 to 85 mg/kg in rats. Signs of overdose include dehydration and an imbalance of electrolytes in the body.

Midamor Novel Uses: Which Conditions Have a Clinical Trial Featuring Midamor?

Presently, 53 active trials are being conducted to assess the utility of Midamor in treating Hypokalemia, Bartter's Syndrome and Congestive Heart Failure.
Condition
Clinical Trials
Trial Phases
Hypokalemia
0 Actively Recruiting
Congestive Heart Failure
11 Actively Recruiting
Not Applicable, Phase 1, Phase 2
Hypertensive disease
27 Actively Recruiting
Not Applicable, Phase 1, Phase 2, Phase 3
Nephrolithiasis
0 Actively Recruiting
kaliuretic diuretics
0 Actively Recruiting
Ascites
2 Actively Recruiting
Not Applicable, Phase 2
Polyuria
0 Actively Recruiting
Metabolic Alkalosis
0 Actively Recruiting
Bartter Syndrome
0 Actively Recruiting
lithium
0 Actively Recruiting

Midamor Reviews: What are patients saying about Midamor?

3.3Patient Review
11/4/2015
Midamor for High Blood Pressure
I had a really bad reaction to this medication after consuming alcohol. I was vomiting for hours and ended up in the ER because I couldn't even drink water. They did an endoscopy and found that my throat had closed up. I'm now worried about the long-term side effects of this drug, as they mimic my existing eye conditions.
2.3Patient Review
9/15/2012
Midamor for High Blood Pressure
I've been urinating frequently, and my muscles have become weak and uncoordinated. This product has not alleviated these issues at all.

Patient Q&A Section about midamor

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What type of diuretic is Midamor?

"Midamor is a water pill that helps prevent your body from absorbing too much salt and keeps your potassium levels from getting too low. It's used to treat or prevent hypokalemia (low potassium levels in the blood) in people with high blood pressure or congestive heart failure."

Answered by AI

Is Midamor a loop diuretic?

"MIDAMOR (amiloride) has been shown to decrease the enhanced urinary excretion of magnesium when used with a thiazide or loop diuretic. MIDAMOR (amiloride) also has potassium-conserving activity in patients receiving kaliuretic-diuretic agents."

Answered by AI

Does Midamor lower potassium?

"Amiloride may cause your body to retain potassium. This is especially likely if you have diabetes, take other diuretics, take medications that can increase potassium in the blood, or if you're over 65."

Answered by AI

What is Midamor used for?

"Amiloride is a medication used to help treat heart conditions like high blood pressure, heart failure, or fluid retention. It is often used in combination with other medications like diuretics and thiazide diuretics. Amiloride can also help to prevent low blood potassium levels that can be caused by other medications."

Answered by AI

Clinical Trials for Midamor

Image of U Health in Miami, United States.

Cuffless PPG Monitor for High Blood Pressure

18+
All Sexes
Miami, FL
This study aims to validate the accuracy and reliability of blood pressure (BP) estimates obtained over 24 hours using a PPG-based chest-patch device compared to the gold standard ambulatory blood pressure monitoring (ABPM) method using an upper arm cuff-based oscillometric BP device, in both hypertensive and normotensive individuals referred by their provider to undergo a 24-hours ABPM for clinical indication. The Awake/Asleep test, which is the primary test recommended for automated wearable cuffless BP devices that are cuff-calibrated (based on the 2023 European Society of Hypertension (ESH) recommendations for the validation of cuffless blood pressure measuring devices), will be conducted in this study. The secondary aim of the study is to assess the feasibility and convenience of the PPG-based device.
Waitlist Available
Has No Placebo
U Health (+1 Sites)Ziad Zoghby, M.D., M.B.A.Biobeat Technologies Ltd.
Have you considered Midamor clinical trials? We made a collection of clinical trials featuring Midamor, we think they might fit your search criteria.Go to Trials
Image of Virginia Commonwealth University in Richmond, United States.

Endovascular Treatment for Stroke

18+
All Sexes
Richmond, VA
Endovascular therapy (EVT) has proven to be more beneficial for patients with AIS caused by large vessel occlusions (LVO) than medical management alone. A recent meta-analysis of 5 RCTs showed that EVT significantly reduced disability at 90 days compared to medical management \[1\]. Despite its obvious benefits, patients may have neurological deterioration despite successful thrombectomy due to ischemia progression, intracranial hemorrhage, re-occlusion, or vasogenic edema. The incidence of early neurological deterioration (END) following EVT for acute stroke has been reported to be ranging from 14.1-35.2% with some studies defining END up to 7 days and some restricting the definition between 6-72 hours post thrombectomy. A small proportion of these patients, approximately 5.9-10.5%, experienced sICH following EVT. Whether END occurs due to ischemic or hemorrhagic it leads to worse outcomes.
Waitlist Available
Has No Placebo
Virginia Commonwealth UniversityAarti Sarwal
Have you considered Midamor clinical trials? We made a collection of clinical trials featuring Midamor, we think they might fit your search criteria.Go to Trials
Image of Wayne Health Mobile Units in Detroit, United States.

Text Message Reminders for High Blood Pressure

18+
All Sexes
Detroit, MI
This project is part of the ACHIEVE GREATER (Addressing Cardiometabolic Health In Populations Through Early PreVEntion in the GREAT LakEs Region) Center (IRB# 100221MP2A), the purpose of which is to improve cardiometabolic health in two uniquely comparable cities: Detroit, Michigan, and Cleveland, Ohio. The ACHIEVE GREATER Center involves separate but related projects that aim to improve cardiometabolic health outcomes through better risk factor control for three chronic conditions that are of tremendous public health importance, (hypertension (HTN), heart failure, and coronary heart disease), all of which contribute significantly to premature death in Detroit and Cleveland. The present study is the prospective observational cohort component of ACHIEVE P1- EPI (Project 1) of the ACHIEVE GREATER Center and serves to characterize the population of patients with blood pressure (BP) levels above normal attending The Wayne Health Mobile Health Unit (MHU) events to better understand key factors (e.g., social determinants of health) that convey information about baseline BP levels and related clinical outcomes (e.g., follow-up clinic visits, BP control, and cardiovascular events).
Recruiting
Has No Placebo
Wayne Health Mobile UnitsSteven J Korzeniewski, PhD
Image of University of Alberta in Edmonton, Canada.

Egg White Powder for High Blood Sugar and High Blood Pressure

18 - 70
All Sexes
Edmonton, Canada
Bioactive peptides derived from food proteins show potential for improving human health. One of such promising peptides is namely IRW made from egg white hydrolysate and composed of three peptides. This is a feasibility study to assess the acute effect of IRW in egg white hydrolysate for the management of high sugar and blood pressure. Participants at high risk of type 2 diabetes (T2D) or having T2D will undergo 4 consecutive treatments of 1 day each (randomly), during which they will consume a standardized breakfast with a smoothie containing different protein powders. Each treatment will be separated by a minimum of 1-week. Participants in the healthy control group will undergo 1 treatment only (one day).
Phase 1
Waitlist Available
University of AlbertaJianping Wu, PhD
Image of Ronald Reagan UCLA Medical Center in Los Angeles, United States.

Next Day Clinic for Patient Care

18+
All Sexes
Los Angeles, CA
The Next Day Clinic (NDC) is a quality improvement initiative that will be launched and operated by UCLA Health starting July 22, 2024. Its goals are to improve patient care and safety and to maximize cost effectiveness. The way it does this is by identifying patients in the ED who would normally be admitted for low-acuity conditions, and diverting them to a high-acuity clinic the following day called the NDC. This will help decompress the ED and the hospital, and allow for overall higher quality care. The Health System has partnered with UCLA's Healthcare Value Analytics and Solutions \[UVAS\] group which specializes in these types of program evaluations. The analysis conducted by the study team will be used to directly inform NDC operations, scaling, and future plans.
Recruiting
Has No Placebo
Ronald Reagan UCLA Medical Center
Have you considered Midamor clinical trials? We made a collection of clinical trials featuring Midamor, we think they might fit your search criteria.Go to Trials
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security